Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Claudine El Beyrouty"'
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:724-740
Streptococcus pneumoniae (pneumococcus) remains a significant cause of both mild infections such as otitis media, sinusitis, and bronchitis and more severe manifestations such as bacteremia, pneumonia, and invasive pneumococcal disease. Several key s
Publikováno v:
Clinics in Laboratory Medicine. 40:509-520
Misuse of antibiotics, including unnecessary use or inappropriate selection, may result in side effects and poor outcome in individual patients, as well as contribute to the spread of antimicrobial resistance. Antimicrobial stewardship programs exist
Publikováno v:
Open Forum Infectious Diseases
Background The management of COVID-19 poses diagnostic challenges with regard to concomitant bacterial pneumonia. This may result in unnecessary antibiotic therapy. This analysis described the experience of an urban academic medical center’s manage
Publikováno v:
Clinics in laboratory medicine. 40(4)
Misuse of antibiotics, including unnecessary use or inappropriate selection, may result in side effects and poor outcome in individual patients, as well as contribute to the spread of antimicrobial resistance. Antimicrobial stewardship programs exist
Autor:
Esther Molnar, Kenneth Biason, Yi Guo, Deepali Dixit, Michael J. Satlin, Emily L. Heil, Abdulrahman Elabor, Kimberly C. Claeys, Erin K McCreary, Saira B. Chaudhry, Jon Hiles, Dorothy McCoy, Nidhi Saraiya, Jason C. Gallagher, Claudine El-Beyrouty, Madeline A King, Lynette Richards, Christopher M. Bland, Daohai Yu, Jin S Suh, Nikunj Vyas, Bruce M Jones, Xiaoning Lu, Nicole Harrington
Publikováno v:
Open Forum Infectious Diseases. 5
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Autor:
Jason C, Gallagher, Michael J, Satlin, Abdulrahman, Elabor, Nidhi, Saraiya, Erin K, McCreary, Esther, Molnar, Claudine, El-Beyrouty, Bruce M, Jones, Deepali, Dixit, Emily L, Heil, Kimberly C, Claeys, Jon, Hiles, Nikunj M, Vyas, Christopher M, Bland, Jin, Suh, Kenneth, Biason, Dorothy, McCoy, Madeline A, King, Lynette, Richards, Nicole, Harrington, Yi, Guo, Saira, Chaudhry, Xiaoning, Lu, Daohai, Yu
Publikováno v:
Open Forum Infectious Diseases
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Publikováno v:
American Journal of Health-System Pharmacy. 72:1897-1904
In 2005, joint guidelines issued by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) provided the first definition of healthcare-associated pneumonia (HCAP).[1][1] This new classification was added to the exis
Autor:
Dorothy McCoy, Jon Hiles, Madeline King, Vanthida Huang, Nicole Harrington, Tiffany E. Bias, Lynette Richards, Safia Kuriakose, Julianne Gardner, Claudine El-Beyrouty, Jason C. Gallagher, Kenneth Biason, Emily L. Heil
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Ceftazidime-avibactam is a novel cephalosporin–beta-lactamase inhibitor combination that is active against many carbapenem-resistant Enterobacteriaceae (CRE). We describe a retrospective chart review for 60 patients who received ceftazidime-avibact
Publikováno v:
Critical Care Medicine. 47:443
Autor:
Vanthida Huang, Julianne Gardner, Emily L. Heil, Dorothy McCoy, Jon Hiles, Madeline King, Safia Kuriakose, Claudine El-Beyrouty, Jason C. Gallagher, Tiffany E. Bias
Publikováno v:
Open Forum Infectious Diseases. 3